X-116444926-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000598581.3(SLC6A14):c.665C>T(p.Ala222Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000082 in 1,207,249 control chromosomes in the GnomAD database, including 1 homozygotes. There are 29 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000598581.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A14 | NM_007231.5 | c.665C>T | p.Ala222Val | missense_variant | 6/14 | ENST00000598581.3 | NP_009162.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A14 | ENST00000598581.3 | c.665C>T | p.Ala222Val | missense_variant | 6/14 | 1 | NM_007231.5 | ENSP00000470801 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 11AN: 111553Hom.: 0 Cov.: 21 AF XY: 0.0000887 AC XY: 3AN XY: 33823
GnomAD3 exomes AF: 0.0000770 AC: 14AN: 181721Hom.: 0 AF XY: 0.0000603 AC XY: 4AN XY: 66381
GnomAD4 exome AF: 0.0000803 AC: 88AN: 1095696Hom.: 1 Cov.: 28 AF XY: 0.0000720 AC XY: 26AN XY: 361346
GnomAD4 genome AF: 0.0000986 AC: 11AN: 111553Hom.: 0 Cov.: 21 AF XY: 0.0000887 AC XY: 3AN XY: 33823
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2023 | The c.665C>T (p.A222V) alteration is located in exon 6 (coding exon 6) of the SLC6A14 gene. This alteration results from a C to T substitution at nucleotide position 665, causing the alanine (A) at amino acid position 222 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at